All Stories

  1. Decreased expression of acetyl-CoA synthase 2 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma

    Article • Cancer Science, May 2017, Wiley

    Professor TI ZHANG

  2. Different but synergistic effects of bone marrow‑derived VEGFR2+ and VEGFR2‑CD45+ cells during hepatocellular carcinoma progression

    Article • Oncology Letters, November 2016, Spandidos Publications

    Professor TI ZHANG

  3. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma

    Article • Gastroenterology, April 2016, Elsevier

    Professor TI ZHANG

  4. Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models

    Article • Journal of Hematology & Oncology, March 2016, Springer Science + Business Media

    Professor TI ZHANG

  5. metformin and sorafenib

    Article • Cancer Science, February 2016, Wiley

    Professor TI ZHANG

  6. Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models

    Article • PLoS ONE, January 2016, PLOS

    Professor TI ZHANG

  7. HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma

    Article • Tumor Biology, August 2015, Springer Science + Business Media

    Professor TI ZHANG

  8. Adjuvant sorafenib therapy in patients with resected hepatocellular carcinoma: evaluation of predictive factors

    Article • Cancer Immunology Immunotherapy, March 2015, Springer Science + Business Media

    Professor TI ZHANG

  9. The Indications for Hepatectomy for Multinodular Hepatocellular Carcinoma: Experience from a Single Institution

    Article • Digestive Surgery, January 2015, Karger Publishers

    Professor TI ZHANG

  10. Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A meta-analysis with comparison of different types of hepatitis

    Article • Molecular and Clinical Oncology, August 2014, Spandidos Publications

    Professor TI ZHANG

  11. Adjuvant sorafenib reduced mortality and prolonged overall survival and post-recurrence survival in hepatocellular carcinoma patients after curative resection: A single-center experience

    Article • BioScience Trends, January 2014, International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

    Professor TI ZHANG

  12. Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects

    Article • BioScience Trends, January 2014, International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

    Professor TI ZHANG

  13. Sorafenib combined with cryoablation to treat unresectable hepatocellular carcinoma

    Article • Chinese Journal of Cancer Research, September 2011, Chinese Journal of Cancer Research

    Professor TI ZHANG

  14. Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells

    Article • Cancer Letters, April 2010, Elsevier

    Professor TI ZHANG

  15. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma

    Article • Journal of Cancer Research and Clinical Oncology, March 2010, Springer Science + Business Media

    Professor TI ZHANG

  16. Clinical Significance of Lymph Node Metastasis in Patients Undergoing Partial Hepatectomy for Hepatocellular Carcinoma

    Article • World Journal of Surgery, February 2010, Springer Science + Business Media

    Professor TI ZHANG

  17. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma

    Article • Digestive and Liver Disease, January 2009, Elsevier

    Professor TI ZHANG